Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04586257
Other study ID # 34142/9/20
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 15, 2020
Est. completion date March 30, 2024

Study information

Verified date April 2024
Source Tanta University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be carried out on 80 patients who will be presented for different spine surgeries under general anesthesia and regional anesthesia technique in Tanta university hospitals. The study was approved by the research ethics committee of the faculty of medicine. Patients will be admitted to the OR where induction of general anesthesia was started and then, the patients will be randomly distributed into two equal groups; - - Group I (40 patients) (ESP block): patients in this group will receive ESP block after induction of general anesthesia. - Group II (40 patients) (TLIP block): patients in this group will receive TLIP block after induction of general anesthesia Measurements; - The length of hospital stay as the primary outcome Postoperative pain scores and opioid consumption as the Secondary outcome


Description:

This prospective randomized double-blind study will be carried out on 80 adult patients who will be presented for different spine surgeries in Tanta university hospitals after obtaining the approval from the institutional Ethical Committee, informed written consent will be obtained from all the participants. Patients will be randomly classified using a computer-generated software of randomization into 2 groups: - Group I (40 patients) (ESP block): patients in this group will receive ESP block after induction of general anesthesia. - Group II (40 patients) (TLIP block): patients in this group will receive TLIP block after induction of general anesthesia Anesthetic technique - The patients will be assessed preoperatively in the anesthesia clinic. On arrival of patients to the preparation room, an intravenous line will be established and the patient will be connected to a monitor. All the patients will receive pheniramine hydrogen maleate 45.5 mg intravenous as an antihistamine, Cefazolin30 mg/kg, and 40 mg pantoprazole. - Induction of anesthesia will be carried out by fentanyl 1 ug/kg, propofol 1.5 mg/kg, and atracurium 0.5 mg/kg to facilitate tracheal intubation. After securing the airway through a suitable sized endotracheal tube, the patient was connected to a mechanical ventilator with its parameters adjusted to maintain the end-tidal carbon dioxide 34-38 mmHg. - Maintenance of the anesthesia was performed by isoflurane 1.MAC and incremental doses of atracurium 0.1 mg/kg. A temperature probe was inserted in the nasopharynx for core temperature monitoring. The depth of anesthesia was monitored by the bispectral index (Covidien, Mansfield, MA, USA). The BIS values were kept 40-60. An additional bolus dose of fentanyl 0.5 ug/kg was used in case of increase BIS more than 60 or increase in the heart rate or mean arterial pressure by more than 15 % of the baseline values. - All patients received tranexamic acid 30 mg/kg through intravenous infusion. Before skin incision, patients of group I will receive ultrasound-guided ESP block, while patients in group II will receive ultrasound guided TLIP block. - At the end of the surgery, the isoflurane was switched off with reversal of muscle relaxation and awake tracheal extubation and transfer of the patient to the recovery room for postoperative monitoring and supplementation of oxygen through a nasal cannula (2-3 L/min). All the patients will receive 4 mg dexamethasone I .v after induction of anesthesia and 4 mg of ondansetron i.v at the end of the surgery to guard against postoperative nausea and vomiting. All the patients received routine postoperative analgesia in the form of paracetamol 1 gm i.v infusion every 6 hours and ketorolac 30 mg i.v every 12 hours. Rescue analgesia in the form of morphine 3 mg i.v was administrated when the pain score was more than 3.


Recruitment information / eligibility

Status Completed
Enrollment 93
Est. completion date March 30, 2024
Est. primary completion date March 30, 2024
Accepts healthy volunteers No
Gender All
Age group 21 Years to 70 Years
Eligibility Inclusion Criteria: - Adult patients of both sexes aged (21-70 years) with ASA physical status I-III scheduled for spine surgeries. Exclusion Criteria: - Patient refusal - Body mass index (BMI) less than 18 or higher than35 kg/m2 - Pregnant - History of relevant allergy to related perioperative medications - Previous lumbar spine surgery - Existing contraindications to nerve block such as coagulopathy, local and systemic infection - Hepatic or renal insufficiency - Chronic opioid use

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Erector spinae plane block
While patients in the prone position, 1.4-5.1 MHz low-frequency probe (C5-1s convex transducer) will be first placed in a longitudinal orientation in the midline to identify the spinous process of at the appropriate lumbar level, then it will be scanned laterally about 2-3 cm until visualization of the paraspinal muscles and the transverse process at the same time. After standard sterilization, a 21-G short bevel nerve block needle will be advanced in a cephalad-to-caudal direction, in-plane under real- time ultrasound guidance, through skin, subcutaneous tissue, and erector spinae muscles until reaching the transverse process. After negative aspiration of blood or cerebral spinal fluid, a small volume of local anesthetic was injected to confirm the position of the needle tip between the erector spinae muscles and the transverse process. A total of 20 ml of 0.0.25% plain bupivacaine will be incrementally injected with intermittent negative aspiration on each side.
Throacolumbar interfacial plane block
USG-guided TLIP block will be performed using a high-frequency linear probe while the patient in prone position. The probe will be covered with sterile sheath positioned transversally in a midline position at approximately the level of the 3rd lumbar vertebra (L3). The corresponding spinous process and interspinal muscles will be identified, and the probe will be slid laterally to identify the multifidus (MF) muscle and longissimus (LG) muscle. Sliding the probe from midline to laterally helps in the correct identification of various muscles. After identifying the muscles, TLIP block will be performed aseptically on both sides of L3 vertebra. Under ultrasound guidance, an insulated echogenic needle will be inserted in-plane in a lateral to medial orientation in-plane USG guided through the belly of LG toward the MF. When needle reach deep to middle of MF/LG interface, 20 ml 0.25% bupivacaine will be injected after negative aspiration. The block will be administered bilaterally.

Locations

Country Name City State
Egypt Faculty of Medicine Tanta Algharbia

Sponsors (1)

Lead Sponsor Collaborator
Tanta University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary length of hospital stay The time interval in days from the day of the surgery till discharge of the patient from the hospital. Within 7 days of the surgery
Secondary postoperative pain scores Postoperative Numerical rating score (NRS) every 2 hours in the first six hours, then every 4 h till 24 h. When NRS scores reach 4 or more, 3 mg of i.v morphine will be given and can be repeated if required with calculation of the total postoperative morphine consumption in mg in the first 24 hours after surgery and the time to the first request of rescue analgesia Within the first 24 hours after surgery
Secondary The postoperative opioid consumption The total dose of morphine consumed in the first 24 hours after surgery Within the first 24 hours after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04451473 - Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery N/A
Recruiting NCT04909567 - Optimization of Patients' Physical and Mental Status Prior to Colorectal Cancer Surgery N/A
Recruiting NCT06103526 - Immunonutrition in ERAS Protocols in Gynecologic Oncology N/A
Active, not recruiting NCT06088082 - "Analgesic Efficacy of Combined Transversus Abdominis Plane Block and Posterior Rectus Sheath Block in Patients Undergoing Laparoscopic Appendectomy" Phase 3
Completed NCT04645654 - Brief Postoperative Hypnosis Intervention as Multimodal Analgesia After Major Abdominal Surgery N/A
Completed NCT04438590 - Kelulut Honey as an Alternate Source of Carbo-Loading in Abdominal Surgery Involving the Digestive System N/A
Completed NCT04873544 - Enhanced Recovery After Surgery Protocols in Total Knee Arthroplasty Via Midvastus Approach N/A
Recruiting NCT05617768 - Enhanced Recovery After Surgery (ERAS)Guidelines in Mitral Valve Surgeries, Questionnaire
Not yet recruiting NCT06066190 - Web-Based Education on ERAS Protocols Applied in Gynecological and Obstetric Surgery N/A
Completed NCT05665712 - Pediatric Enhanced Recovery After Cardiac Surgery
Recruiting NCT05962684 - A Greek-designed ERAS Protocol in Elective Craniotomy
Recruiting NCT05738902 - Adherence and Compliance to ERAS in Gynecological Surgery
Not yet recruiting NCT06424938 - Postoperative Analgesia in Major Gynecological Cancer Surgeries N/A
Recruiting NCT05231473 - Impact Of The Nurse Enhanced Recovery After Surgery Coordinator On The Compliance In Colorectal Surgery (nursERAS-BCN) N/A
Enrolling by invitation NCT04964856 - Enhanced Recovery After Surgery Exercise Improve Perioperative Frailty N/A
Completed NCT05033899 - Enhanced Recovery After Spinal Surgery Protocol Versus Conventional Care in Non Insulin Diabetic Patients ( ERAS ) N/A
Completed NCT04870242 - Studding the Implementation of ERAS Protocols in Pediatric Surgery
Recruiting NCT03949114 - Rehabilitation Intervention on Prevention of Postoperative Delirium N/A
Recruiting NCT06050551 - Pigtail or Chest Tube Placement After Uniportal Video-assisted Thoracoscopic Surgery N/A
Active, not recruiting NCT05884164 - ESPB Versus PVPB Regarding Their Effect on Peri-operative Opioid Consumption in Patients Undergoing Minimally Invasive Mitral Valve Replacement N/A